Oncology
topic on 5 shows · 7 statements across 7 episodes
the Y Combinator Startup Podcast 
Latent Space 
No Priors 
Capital Allocators 
the MAD Podcast
7 statements about Oncology, every show
Bilgen: Starting in oncology would have made initial commercialization far harder
“Because if we started, I think, on the oncology side, it would have been far more difficult to achieve that initial successful commercialization that gave us more resources to be able to build, you know, new tests and improve the existing tests.”
Fortuna: Oncologists and cardiologists spend up to 60 minutes pre-reviewing charts
“In certain specialties like oncology or cardiology, before they go into the visit with the patient, they can often spend like 10 minutes or up 30 minutes or 60 minutes looking at the chart. They're going to look at labs and images and, you know, other data abo…”
Koller: Insitro expands into metabolism and oncology due to standard-of-care data
“The other areas that we've gone into are metabolism and oncology, because again, those are areas where relevant, disease relevant data, That is high content, that is unbiased and truly informative about the disease state is collected quite abundantly as part o…”
Futch says US drug pricing headwinds spare only oncology and orphan diseases
“Pricing headwinds in the U.S. That really applies to almost all therapeutic categories other than Orphan and oncology.”
Hynes: Roughly 40% of biopharma R&D is allocated to oncology
“About 40% of the Industries of R&D now is going to oncology.”
Hoffman: Oncology will see huge innovation in the next 20 years
“So the probably oncology is a place where we'll probably will see some innovation because there's a defined data set. There's, there are definitely some vendors today that have access to really good oncology data. So I expect that we'll see a lot of really gre…”